Straumann Holding AG Gross Profit 2012-2024 | SAUHY

Straumann Holding AG annual/quarterly gross profit history and growth rate from 2012 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Straumann Holding AG gross profit for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG gross profit for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG annual gross profit for 2024 was $2.026B, a 1.75% increase from 2023.
  • Straumann Holding AG annual gross profit for 2023 was $1.991B, a 8.27% increase from 2022.
  • Straumann Holding AG annual gross profit for 2022 was $1.839B, a 9.13% increase from 2021.
Straumann Holding AG Annual Gross Profit
(Millions of US $)
2024 $2,026
2023 $1,991
2022 $1,839
2021 $1,685
2020 $1,098
2019 $1,208
2018 $1,042
2017 $854
2016 $730
2015 $640
2014 $611
2013 $579
2012 $567
2011 $598
Straumann Holding AG Quarterly Gross Profit
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.586B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.020B 21.74
Becton Dickinson (BDX) United States $49.466B 12.25
Cardinal Health (CAH) United States $36.861B 19.31
Labcorp (LH) United States $20.839B 16.90
West Pharmaceutical Services (WST) United States $15.149B 31.75
Cooper (COO) United States $13.655B 17.60
Align Technology (ALGN) United States $13.115B 26.03
Henry Schein (HSIC) United States $8.519B 14.61
Merit Medical Systems (MMSI) United States $5.616B 27.15
DENTSPLY SIRONA (XRAY) United States $3.185B 9.51
CONMED (CNMD) United States $1.756B 13.14
STAAR Surgical (STAA) United States $0.882B 0.00
Lifevantage (LFVN) United States $0.164B 16.95
Pro-Dex (PDEX) United States $0.131B 14.30